Genmab A/S
GMAB
$25.85
-$0.51-1.94%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | 61.17% | 42.50% | 46.06% | 82.85% |
| Total Depreciation and Amortization | -- | 23.75% | 18.92% | 7.95% | 26.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -209.34% | -30.69% | -21.21% | -72.44% |
| Change in Net Operating Assets | -- | -145.25% | 40.21% | 35.90% | -159.55% |
| Cash from Operations | -- | 9.77% | 45.23% | 49.63% | 8.67% |
| Capital Expenditure | -- | -30.34% | 16.90% | 15.34% | 47.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 95.35% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -80.79% | 255.94% | 259.23% | 389.54% |
| Cash from Investing | -- | 96.83% | -221.31% | -239.56% | -707.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 49.64% | 69.86% | 68.94% | 73.99% |
| Issuance of Common Stock | -- | -12.30% | -55.81% | -62.31% | -62.75% |
| Repurchase of Common Stock | -- | -38.05% | -459.56% | -470.95% | -28.26% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 8.39% | -485.57% | -511.65% | -572.88% |
| Foreign Exchange rate Adjustments | -- | 145.62% | 329.55% | 136.36% | 109.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 157.19% | -256.49% | -304.40% | -228.53% |